Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$0.88 - $2.19 $357,392 - $889,420
-406,128 Reduced 72.44%
154,489 $163,000
Q4 2022

Feb 10, 2023

BUY
$1.27 - $2.26 $6,404 - $11,397
5,043 Added 0.91%
560,617 $852,000
Q3 2022

Nov 10, 2022

BUY
$1.41 - $2.79 $604,234 - $1.2 Million
428,535 Added 337.33%
555,574 $1.18 Million
Q2 2022

Aug 05, 2022

BUY
$1.15 - $2.53 $110,922 - $244,028
96,454 Added 315.36%
127,039 $170,000
Q1 2022

May 12, 2022

BUY
$1.91 - $3.98 $58,417 - $121,728
30,585 New
30,585 $65,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $281M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.